"10.1371_journal.pone.0150214","plos one","2016-02-25T00:00:00Z","Frank J Overdyk; Oonagh Dowling; Joseph Marino; Jiejing Qiu; Hung-Lun Chien; Mary Erslon; Neil Morrison; Brooke Harrison; Albert Dahan; Tong J Gan","Department of Anesthesiology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, NY, United States of America; North American Partners in Anesthesia, Melville, NY, United States of America; Department of Medicine, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, United States of America; Covidien Healthcare Economics and Outcomes Research, Mansfield, MA, United States of America; Covidien Respiratory and Monitoring Solutions, Boulder, CO, United States of America; Harrier Consultancy, Lancaster, United Kingdom; Boulder Medical Writing, Boulder, CO, United States of America; Department of Anesthesiology, Leiden University Medical Center, Leiden, Netherlands; Department of Anesthesiology, Stony Brook University (SUNY), Stony Brook, NY, United States of America","Conceived and designed the experiments: FJO OD JM JJQ HLC ME NM BH AD TJG. Performed the experiments: JQ HLC. Analyzed the data: FJO OD JM JQ HLC ME NM BH AD TJG. Wrote the paper: FJO OD JM JJQ HLC ME NM BH AD TJG.","This analysis was supported by Covidien Healthcare Economics and Outcomes Research. JQ, HLC, and ME are Covidien employees. FJO and JM are employed by North American Partners in Anesthesia. NM is employed by Harrier Consultancy. BH is employed by Boulder Medical Writing. FJO and TJG report grant support and honorarium from Covidien, unrelated to the submitted work. NM and BH report personal fees from Covidien during the conduct of the study. AD reports grants and personal fees from Mundipharma Int. Cambridge, UK; grants from Galleon Pharmaceuticals Corp. PA, USA; grants and personal fees from Revive Therapeutics, Ontario, Canada; grants and personal fees from Gruenenthal GmbH, Aachen, Germany; grants from Royal Dutch Shell, The Hague, Netherlands; grants and personal fees from MSD Netherlands, outside the submitted work. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2016","02","Frank J Overdyk","FJO",10,TRUE,10,2,10,10,TRUE,TRUE,FALSE,0,NA,FALSE
